Form 4 for ATRC AtriCure, Inc.
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-31 · accession 0001209191-22-000387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-04 | 2021-12-31 | ATRC | Doraiswamy Vinayak | CSO | A - Grant | $59.10 | +24 | 16.9K | +0.1% | +$1,418 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-31 | A | A | 24 | $59.10 | 16,899 | D | — | — | (F1) Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021. (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53. |